期刊文献+

甲状腺乳头状癌复发及持续状态再次手术临床分析 被引量:2

Clinical analysis of reoperation for recurrent/persistent papillary thyroid carcinoma
原文传递
导出
摘要 目的分析探讨甲状腺乳头状癌(papillary thyroid carcinoma,PTC)再次手术的原因及对预后的影响因素,总结经验,规范手术范围及方式,减少可避免的再次手术。方法回顾性分析2013年1月至2017年12月重庆医科大学附属第一医院乳腺甲状腺外科行再次手术的60例PTC患者的临床资料,通过不同区域肿瘤复发的临床特征描述及比较其与再次手术后复发的差异,分析再次手术原因及影响再复发的危险因素。结果本研究中,患侧中央区及侧区淋巴结转移(lymph node metastasis,LNM)有11例(18.3%);仅有患侧侧区淋巴结转移(lateral lymph node metastasis,LLNM)有34例(56.7%);喉返神经后方LNM有6例(10.0%);对侧LLNM有10例(16.7%)。单因素χ2分析发现再次手术后复发转移的患者,初次手术时年龄更大(P=0.003),LNM数目更多(P=0.037),再次手术前甲状腺球蛋白(thyroglobulin,Tg)水平更高(P=0.034)。多因素分析中,初次手术LNM数目(OR=1.174,P=0.008)、年龄(OR=1.130,P=0.014)及再次手术前Tg水平(OR=1.156,P=0.040)是手术后复发转移的独立危险因素。结论局部淋巴结复发及持续状态是致再次手术的主要原因,初次手术LNMN及年龄影响再次手术预后。再次手术操作难度大、风险较高,术中应配合神经监测和冰冻活检来加强喉返神经及甲状旁腺功能的保护。 Objective To analyze the causes of reoperation for papillary thyroid carcinoma(PTC)and summarize experience to reduce avoidable reoperations.Methods We retrospectively studied 60 patients with PTC who underwent reoperation in the Department of Breast and Thyroid Surgery of the First Affiliated Hospital of Chongqing Medical University from Jan.2013 to Dec.2017.Through the clinical description of the recurrence of tumors in different regions and the differences between the recurrence of reoperation and Clinical characteristics,the cause of the reoperation and the risk of recurrence are analyzed.Results Of the 60 PTC patients included in this study,11(18.3%)had lymph node metastasis(LNM)in the central plus lateral compartment of the affected side;34(56.7%)only had lymph node metastasis of the affected side compartment;There were 6(10.0%)metastasis to the lymph node posterior to right recurrent laryngeal nerve(LN-prRLN);10(16.7%)patients had lymph node metastases in the contralateral compartment;We found that patients with recurrence after reoperation were older(P=0.003),the more number of lymph node metastases(LNMN)(P=0.037),and with higher level of thyroglobulin than that before reoperation(P=0.034);and multivariate analysis indicated that LNMN in initial operation(OR=1.174,P=0.008),age(OR=1.130,P=0.014)and Tg level before reoperation(OR=1.156,P=0.040)were all independent predictors for recurrence after reoperation.Conclusions Local lymph nodes recurrence/persistence is the main reason for reoperation in our study.LNM of the initial operation and age affect the prognosis after reoperation.Reoperation is difficult and risky,and attention should be paid to the protection of parathyroid glands and recurrent laryngeal nerve by nerve monitoring and frozen biopsy.
作者 邓畅 杨志欣 苏新良 Deng Chang;Yang Zhixin;Su Xinliang(Department of Hepatobiliary and Thyroid and Breast and Vascular Surgery,the Central Affiliated to Chongqing University of Technology,Chongqing 400054,China;Department of Breast and Thyroid,Guiyang City Maternal and Child Health Care&Guiyang City Children’s Hospital,Guiyang 550003,China;Department of Endocrinology and Breast Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《中华内分泌外科杂志》 CAS 2023年第6期724-728,共5页 Chinese Journal of Endocrine Surgery
基金 2020重庆医科大学智慧医学研究项目(ZHYX202001)。
关键词 甲状腺乳头状癌 淋巴结转移 喉返神经 复发及持续状态 再次手术 Papillary thyroid carcinoma Lymph node metastasis Recurrent laryngeal nerve Recurrence or persistence state Reoperation
  • 相关文献

参考文献4

二级参考文献52

  • 1李向阳,丁友宏,邱亮,严士光,闫坤.分化型甲状腺癌再次手术97例临床分析[J].山东医药,2013,53(30):62-63. 被引量:5
  • 2边学,徐震纲,张彬,刘文胜,毛传远,唐平章.分化型甲状腺癌的颈淋巴转移规律[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):599-602. 被引量:67
  • 3PELLEGRITI G, FRASCA F, REGALBUTO C, et al.Worldwide increasing incidence of thyroid cancer: updateon epidemiology and risk factors[J]. J Cancer Epidemiol,2013: 965212.
  • 4ROBBINS K T, CLAYMAN G, LEVINE P A, et al. Neckdissection classification update: revisions proposed by theAmerican Head and Neck Society and the American Academyof Otolaryngology-Head and Neck Surgery[J]. ArchOtolaryngol Head Neck Surg, 2002, 128(7): 751-758.
  • 5TAKADA H, KIKUMORI T, IMAI T, et al. Patterns of lymphnode metastases in papillary thyroid carcinoma: results fromconsecutive bilateral cervical lymph node dissection [J].World J Surg, 2011, 35(7): 1560-1566.
  • 6KOUVARAKI MA, SHAPIRO SE, FORANGE BD, et al. Roleof preoperative ultrasonography in the surgical management ofpatients with thyroid cancer [J].Surgery, 2003, 134: 946-955.
  • 7TUTTLE R M, HADDAD R I, BALL D W, et al. Thyroidcarcinoma, version 2. 2014. [J]. J Natl Compr CancNetw, 2014, 12(12): 1671-1680.
  • 8PASQUALI D, SANTORO A, BUFO P, et al. Upregulation ofendocrine gland-derived vascular endothelial growth factorin papillary thyroid cancers displaying infiltrative patterns,lymph node metastases, and BRAF mutation [J]. Thyroid,2011, 21(4): 391-399.
  • 9ROH J L, KIM J M, PARK C I. Central lymph node metastasisof unilateral papillary thyroid carcinoma: patterns andfactors predictive of nodal metastasis, morbidity, andrecurrence[J]. Ann Surg Oncol, 2011, 18(8): 2245-2250.
  • 10SUN S P, ZHANG Y, CUI Z Q, et al. Clinical application ofcarbon nanoparticle lymph node tracer in the Ⅵ region lymphnode dissection of differentiated thyroid cancer[J]. GenetMol Res, 2014, 13(2): 3432-3437.

共引文献201

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部